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O B J E C T I V E S We sought to explore the relationship between established parameters of reperfusion and
the extent of myocardial damage measured by the delayed enhancement (DE) of iodinated contrast by
multidetector computed tomography (MDCT) immediately after primary percutaneous coronary intervention (PCI).
B A C KG ROUND Early detection of myocardial viability should be valuable for risk stratiﬁcation of
patients with reperfused acute myocardial infarction (AMI).
METHOD S Consecutive patients without a history of previous AMI who underwent primary PCI for
an ST-segment elevation AMI were examined by DE-MDCT without an additional contrast injection
immediately after completion of PCI. No medication was administrated to lower the heart rate. Dose
modulation lead to an approximate mean radiation dose of 5.5 mSv.
R E S U L T S Thirty patients constituted the study population. Mean age was 61.4 15.6 years, 24 (80%) were
men, and 4 (13%)were diabetic. Although post-procedural Thrombolysis InMyocardial Infarction (TIMI) ﬂowgrade
3 was achieved in all patients, DE was detected in 14 (47%) patients. Age, sex, hypertension, diabetes, smoking
history, serum creatinine levels, and pain duration were not associated with the presence of DE. Door-to-balloon
time (DE 70.3 33.6 min vs. non-DE 98.3 70.7 min, p 0.19) and lesion crossing time (DE 18.6 11.4 min vs.
non-DE 16.4 9.6 min, p 0.58) did not differ between groups. The TIMI myocardial perfusion grade (0 to 1 vs.
2 to 3) after stent implantation and electrocardiogram ST-segment resolution (50% or50%) were associated
with the presence of DE (p 0.001 and p 0.02, respectively). Pre-discharge left ventricular ejection fraction was
lower in DE than in non-DE patients (44.6 12.4% vs. 54.1 10.3%, respectively, p 0.05). Hospitalization days
(DE 5.6 3.8 vs. non-DE 4.8 1.0, p 0.41) and 6-month cardiac events (DE 3 of 14 vs. non-DE 1 of 16, p 0.22)
did not differ between groups.
CONC L U S I O N S Early detection of myocardial viability immediately after primary PCI by the use of
DE-MDCT is related to clinical and angiographic parameters of myocardial reperfusion. (J Am Coll Cardiol Img
2009;2:1072–81) © 2009 by the American College of Cardiology Foundation
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1073ith the advent of primary percutane-
ous coronary intervention (PCI), the
prognosis of patients with acute myo-
cardial infarction (AMI) has improved
ignificantly (1). However, clinical outcomes are not
nly associated with the final angiographic flow in
he epicardial artery but also with flow in the
yocardium (2–5). Accurate and early distinction
See page 1082
etween viable and nonviable myocardium would
epresent a valuable instrument for risk stratification
f reperfused AMI patients by providing the clini-
ian the ability to discriminate between stunned and
rreversibly damaged myocardium.
The rapidly evolving field of multidetector com-
uted tomography (MDCT) coronary angiography
as lead investigators to explore noncoronary appli-
ations of the technique. Recently, the authors of
everal studies (9–14) established that the identifi-
ation of myocardium delayed enhancement (DE)
f iodinated contrast by MDCT (DE-MDCT) is a
irect marker of the presence, extent, and morphol-
gy of irreversible damage of the myocardium. The
hysiopathological mechanism is similar to the
adolinium in cardiac magnetic resonance imaging.
ecause 75% of myocardial mass is intracellular,
upture of the sarcolemmal membrane and subse-
uent entrance of contrast material enables an
ncrease in the volume of distribution as the result
f a combination of delayed wash-in and wash-out
inetics of nonviable tissue (9–13).
The absence of hyperenhancement in DE-
DCT has been related to viable myocardium
ssessed by low-dose dobutamine echocardiography
15). Nevertheless, the association between clinical
nd angiographic parameters of reperfusion and
yocardium viability evaluated by DE-MDCT re-
ains unknown. We therefore sought to explore
he relationship between established parameters of
eperfusion and the presence and extent of myocar-
ial damage measured by DE-MDCT immediately
fter primary PCI.
E T H O D S
onsecutive patients without a history of previous
yocardial infarction (MI) who underwent primary
CI for a ST-segment elevation myocardial infarction
STEMI) were examined with DE-MDCT without
dditional iodine injection immediately after comple-
ion of PCI. Exclusion criteria included a history of trevious MI, hemodynamic instability, and the pres-
nce of a pacemaker or implantable devices.
Patients were included if they were 18 years of
ge with the first MI presenting within 12 h of their
ymptom onset. We defined STEMI as ST-
egment elevation of at least 1 mm in 2 contigu-
us leads with associated chest pain persisting 30
in. Pre-infarction angina was defined as recent
nset discomfort or chest pain during the previous 7
ays. The degree of ST-segment reduction after
CI was considered as a dichotomic (50% vs.
50%) variable. The peak creatine kinase value was
valuated in every patient. In-hospital morbidity
as evaluated as electrical (ventricular tachycardia,
entricular fibrillation) and mechanical (acute ven-
ricular septal defect, acute mitral insufficiency, and
upture of the ventricular free wall) com-
lications and worst Killip-Kimbal class
chieved during hospitalization. In case
ore than 1 complication was present, the
ighest ranked was computed. Pre-
ischarge and 6-month left ventricular
jection fraction (LVEF) were measured
y electrocardiogram (ECG)-gated radio-
uclide ventriculography. The incidence
f major cardiac and cerebrovascular
vents defined as the composite of death,
onfatal AMI, stroke, and clinically driven
arget vessel revascularization within 6
onths was recorded.
ngiography: analysis and deﬁnitions. All
atients received aspirin and load dose of
00-mg clopidogrel. Administration of gly-
oprotein IIb/IIIa receptor antagonists (tiro-
ban) was administrated at discretion of the
reating physician, and infusion was started
efore PCI. Invasive coronary angiography
as performed by the use of meglumine
odium diatrizoate (Mallinckrodt, St. Louis, Mis-
ouri). The culprit coronary artery was defined by use
f the ECG and the angiographic result. Post-
rocedural suboptimal coronary flow was defined as
nal Thrombolysis In Myocardial Infarction (TIMI)
ow grade2 and normal flow as TIMI flow grade 3
n the infarct-related artery. The crossing time was
efined as the time elapsed between the first contrast
njection in the infarct related artery and the first
ilation of the culprit lesion. The final TIMI flow
rade and the TIMI myocardial perfusion grade
TMPG) were determined by an independent ob-
erver who was unaware of the CT results to assess
picardial and microvascular coronary blood flow in
A B B
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1074Ten seconds of cine filming were required to
llow some filling of the venous system to evaluate
he washout phase of contrast dye. In brief, and as
reviously described, in TMPG 0 there is minimal
r no myocardial blush; in TMPG 1 dye stains the
yocardium and persists on the next injection; in
MPG 2 dye enters the myocardium but washes
ut slowly so that dye is strongly persistent at the
nd of the injection; and in TMPG 3 there is
ormal entrance and exit of dye in the myocardium
16). A TIMI coronary flow grade 3 in the treated
essel with a residual stenosis30% was considered
uccessful PCI. Total iodine volume and time
asting from the last coronary injection to the CT
can were measured.
E-MDCT acquisition and analysis. Scans were per-
ormed by the use of a 64-channel MDCT scanner
Brilliance 64, Philips Healthcare, Cleveland,
hio) without the administration of medication to
ower the patient’s heart rate. Scan parameters were
collimation of 64  0.625 mm, rotation time
.42 s, tube voltage 120 kV, and tube current of 500
o 600 mAs corresponding to an approximate mean
adiation dose of 5.5 mSv. A dose modulation
rotocol was applied to reduce the radiation dose
uring systole (17). An ECG was recorded simul-
aneous to the CT scan to enable retrospective
ating of the image data. A dedicated cardiac gating
lgorithm was used that identified the same physi-
logical phases of the cardiac cycle while taking into
ccount the nonlinear changes in the individual
ardiac states with the heart rate variations during
he CT acquisition (18). A cardiac adaptive multi-
egment reconstruction technique was used that com-
ined data from consecutive cardiac cycles, thus sig-
ificantly improving temporal resolution between 53
nd 210 ms (19).
All patients underwent 64-slice CT immediately
fter primary PCI. In our institution, the CT
canner is next to the catheterization laboratory. All
cans were acquired without contrast medium in-
ection within a time frame of 40 min from the last
ngiogram. In all patients, images were recon-
tructed at 75% of the cardiac phase by the use of
xial planes, multiplanar reconstructions, and max-
mum intensity projections at 1-mm slice thickness.
hort axis (from base to apex), 2-, 3-, and
-chamber views were obtained initially by the use
f 5-mm slice-reformatted images. The presence of
odine-DE was evaluated by 2 experienced observ-
rs. The number or segments with DE was assessed
y the American Heart Association 17-segment
odel (20), and the percent of segments involved 2as determined. The infarct mass was calculated as
ollows: hyperenhancement mass (g)  Hyperen-
anced area  slice thickness  1.06.
All analyses were performed by the use of dedi-
ated software (Comprehensive Cardiac Analysis,
ersion 3.5, Philips Healthcare, Cleveland, Ohio)
n a CT workstation (Extended Brilliance Work-
pace, Philips Healthcare). The extent of DE was
onsidered transmural if50% of the thickness was
nvolved and subendocardial if 50% was hyperen-
anced (Fig. 1). The primary objective of the study
as to explore the relationship between established
arameters of myocardial reperfusion (ECG ST-
egment resolution and TMPG) and the presence
nd extent of myocardial damage measured by
E-MDCT immediately after primary PCI. The
tudy was approved by our institution=s ethics
ommittee, and all the patients enrolled gave their
ritten informed consent.
tatistical analysis. Discrete variables are presented
s counts and percentages. Continuous variables are
resented as mean  SD or median (25th, 75th
ercentile) as indicated. Comparisons among
roups were performed with independent Student t
ests, chi-square tests, the Fisher exact tests, and
ann-Whitney U tests, as indicated. We explored
orrelations between the peak creatine kinase and
he infarcted mass, the percent of the left ventricle
LV) involved, and the number of segments with
E, using Spearman correlation coefficients. A
-sided p value of 0.05 indicated statistical sig-
ificance. Statistical analyses were performed with
PSS version 13.0 (SPSS Inc., Chicago, Illinois).
E S U L T S
hirty patients constituted the study population.
he mean age was 61.4  15.6 years, 24 (80%)
ere men, and 4 (13.3%) were diabetic. Eighteen
60%) patients had pre-infarction angina. The cul-
rit lesion was the right coronary artery in 15 (50%)
atients, the left circumflex in 5 (16.7%), and the
eft anterior descending in 10 (33.3%) patients. The
aseline TIMI flow grade was 0 in 22 (73%)
atients, 1 in 4 (13%) patients, and 2 (13%) in 4
atients. All patients underwent stent placement in
he infarct related artery. Final TIMI flow grade 3
ith residual stenosis 30% was achieved in all
ases. Mean door-to-balloon time (DTB) was 85.2
7.4 min and the mean crossing time was 17.4 10.3
in. Mean contrast volume administration was19.2  68.7 ml.
i
r
m
8
9
s
(
w
t
d
s
a
c
e
n
c
1
g
r
r
a
(
o
c
p
d
4
e
s
fl
o
t
c
w
p
0
0
D
n
p
n
b
h
o
C
f
s
v
[
L
m
L
(
1
t
L
d
9
s
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 9 , 2 0 0 9
S E P T E M B E R 2 0 0 9 : 1 0 7 2 – 8 1
Rodriguez-Granillo et al.
Early Assessment of Myocardial Viability With CT
1075The median time elapsed between last contrast
njection and CT scan was 16 min (interquartile
ange 12.5 to 20.25 min), within a time frame of 40
in. The mean heart rate during the scan was
0.3 16.5 beats/min, and the mean scan time was
.5  1.2 s. Image quality of all scans was deemed
ufficient. Delayed enhancement was detected in 14
47%) patients; in 11 (79%) patients the extension
as transmural and in 3 (21%) subendocardial. A
otal of 510 segments were evaluated, and DE was
etected in 61 segments (12.1%).
Age, sex, hypertension, diabetes, smoking history,
erum creatinine levels, and pain duration were not
ssociated with the presence of DE (Table 1). Hyper-
holesterolemia was inversely associated with the pres-
nce of DE. The DTB time (DE 70.3 33.6 min vs.
on-DE 98.3  70.7 min, p  0.19) and lesion
rossing time (DE 18.6  11.4 min vs. non-DE
6.4  9.6 min, p  0.58) did not differ between
roups.
Comparative data between groups regarding pa-
ameters of reperfusion and clinical outcomes are
eported in Table 2. The TMPG (0 to 1 vs. 2 to 3)
fter stent implantation and ST-segment resolution
50% or 50%) was associated with the presence
f DE (p  0.001 and p  0.02, respectively). Peak
reatine kinase levels were significantly greater in
atients with DE than in those with viable myocar-
ium (1,531 [interquartile range 442 to 2,177] U/l vs.
61 [interquartile range 253 to 1,114] U/l, p 0.03).
Pre-infarction angina was not associated with the
xtension of necrosis (Table 3). Patients with ST-
Figure 1. Patterns of Delayed Enhancement
(A) Subendocardial (arrowheads) DE detected 29 min after last con
time and lesion crossing time were 60 min and 16 min, respectively
50%, with TIMI ﬂow grade 3 and TMPG 3. (B) Transmural (arrows
total 300 ml) in the left circumﬂex territory of a 53 year-old man. D
min, respectively. After primary PCI, electrocardiographic ST-segmen
delayed enhancement; PCI  percutaneous coronary intervention; T
In Myocardial Infarction myocardial perfusion grade.egment resolution 50% and patients with poor mow at the microvascular level had larger extension
f markers of necrosis (Table 3, Fig. 2). Regarding
he MI territory, anterior wall AMIs had signifi-
antly larger markers of necrosis (Table 3). There
as a significant positive correlation between the
eak creatine kinase and the infarcted mass (r 
.54, p  0.002), the percent LV involved (r 
.56, p  0.001), and the number of segments with
E (r  0.57, p  0.001) (Fig. 3).
Pre-discharge LVEF was lower in DE vs.
on-DE patients (44.6  12.4% vs. 54.1  10.3%,
 0.05). Hospitalization (DE 5.6  3.8 days vs.
on-DE 4.8  1.0 days, p  0.41) did not differ
etween groups. Patients without DE had no in-
ospital complications (Table 2), whereas 6 (43%)
f 14 DE patients had complications (p  0.005).
linical outcome and functional recovery. At 6-month
ollow-up, no patient had died, and there were no
ignificant differences in major cardiac and cerebro-
ascular events (DE 3 of 14 [21%] vs. non-DE 1 of 16
6%], p  0.22). Both at baseline and follow-up,
VEF was significantly greater in patients with viable
yocardium (Table 4). At 6-month follow-up, the
VEF increased from 50.5 11.4% to 55.7 13.7%
p  0.009), representing a relative increment of
4.2% (interquartile range 3.0% to 19.8%). Never-
heless, the absolute and relative differences in
VEF between DE and non-DE patients did not
iffer significantly.
From the subset of patients with 6-month
9mTc-sestamibi gated SPECT (n  22), 374
egments (American Heart Association 17-segment
t injection (total 250 ml) in a 66-year-old man. Door-to-balloon
ter primary PCI, electrocardiographic ST-segment resolution was
ension of myocardium DE (17 min after last contrast injection,
to-balloon time and lesion crossing time were 45 min and 16
solution was 50%, with TIMI ﬂow grade 3 and TMPG 0. DE 
 Thrombolysis In Myocardial Infarction; TMPG  Thrombolysistras
. Af
) ext
oor-
t re
IMIodel) were evaluated, and 41 segments showed
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1076E (11.0%), whereas 333 segments were viable.
unctional recovery was detected in 10 (24%) of 41
E segments, whereas 329 (99%) of 333 viable
egments had normal wall motion at follow-up
p  0.001).
I S C U S S I O N
he main finding of our study was that clinical
nd angiographic parameters of reperfusion were
elated to the presence of DE detected by
E-MDCT. Our findings can be summarized as
ollows: 1) The performance of DE-MDCT
mmediately after primary PCI was fast and
easible, with a median delay between procedures
f 16 min and a mean scan duration of 9.5 s. 2)
espite the fact that recommended DTB time
argets were accomplished and although TIMI
ow grade 3 was achieved after successful primary
Table 1. Demographical and Procedural Characteristics Accordin
DE (n  14)
Demographics
Age (yrs) 58.6 11.2
Male 13/14 (93)
Hypertension 5/14 (36)
Diabetes 3/14 (21)
Hypercholesterolemia 5/14 (36)
Smoking 10/14 (71)
Creatinine (mg/dl) 1.1 0.3
Pre-infarction angina 8/14 (43)
Symptoms duration (h) 5.95 2.65
AMI location
Anterior (n 14) 9/14 (64)
Inferior (n 16) 5/16 (31)
Medical treatment at baseline
Aspirin 2/14 (14)
Statin 3/14 (21)
Beta-blocker 4/14 (29)
ACE inhibitor 2/14 (14)
Procedural data
Tiroﬁban 8/14 (57)
Target lesion
LAD (n 10) 7/10 (70)
LCX (n 5) 2/5 (40)
RCA (n 15) 5/15 (33)
Door-to-balloon time (min) 70.3 33.6
Crossing time (min) 18.6 11.4
Contrast volume (ml) 235.4 78.5
PCI-CT time (min) 17.2 8.0
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; AMI  acute myocardial infarction;
descending; LCX  left circumﬂex; PCI  percutaneous coronary intervention;CI, DE was present in 47% of the patients. 3) Toth ST-segment resolution and TMPG, param-
ters that reflect the functional status of the
yocardium at risk and the patency of coronary
rteries at the microvascular level, respectively,
ere highly related to the presence of DE. 4)
espite the 6-month outcome, which did not
iffer between groups, patients with myocardium
E showed larger enzyme release, lower pre-
ischarge LVEF, and a greater rate of in-hospital
orbidity.
The widely available use of primary PCI has
ignificantly improved the clinical outcome of
TEMI patients. Nevertheless, prognosis of these
atients seems to be related not only to the epicar-
ial flow obtained after revascularization but to the
icrovascular flow achieved as well (6,7). A number
f tools exist that provide insight regarding the
estoration of perfusion in an acute setting, namely
he ECG ST-segment resolution and the TMPG.
the Presence or Absence of Myocardial DE
Non-DE (n  16) p Value
63.9 18.7 0.37
11/16 (69) 0.10
10/16 (63) 0.14
1/16 (6) 0.22
12/16 (75) 0.03
8/16 (50) 0.23
1.1 0.3 0.73
10/16 (63) 0.77
4.92 2.11 0.26
0.07
5/14 (36)
11/16 (69)
3/16 (19) 0.74
8/16 (50) 0.11
4/16 (25) 0.83
9/16 (56) 0.02
5/16 (31) 0.15
0.19
3/10 (30)
3/5 (60)
10/15 (67)
98.3 70.7 0.19
16.4 9.6 0.58
205.0 57.8 0.25
17.2 7.1 0.99
computed tomography; DE  delayed enhancement; LAD  left anterior
 right coronary artery.g tohese parameters are readily available and provide
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1077Table 2. Parameters of Myocardial Reperfusion and Clinical Outcome After Primary Percutaneous Coronary Intervention According
to the Presence or Absence of Myocardial DE
DE (n  14) Non-DE (n  16) p Value
Parameters of reperfusion
TIMI myocardial perfusion grade 0.001
0–1 8/8 (100) 0/8 (0)
2–3 6/22 (27) 16/22 (73)
ECG ST-segment resolution 0.02
50% 6/7 (86) 1/7 (14)
50% 8/23 (35) 15/23 (65)
Clinical outcome
Pre-discharge LVEF (%) 44.6 12.4 54.1 10.3 0.05
Peak creatine kinase (U/l) 1,531 (442–2,177) 461 (253–1,114) 0.03
In-hospital complications
Electrical 2/14 (14) 0/16 (0) 0.21
Mechanical 1/14 (7) 0/16 (0) 0.47
Heart failure 4/14 (29) 0/16 (0) 0.037
Total 6/14 (43) 0/16 (0) 0.005
Hospitalization (days) 5.6 3.8 4.8 1.0 0.41
6-month MACCE 3/14 (21) 1/16 (6) 0.22
Values are n (%), mean  SD, or median (interquartile range).
ECG  electrocardiographic; LVEF  left ventricular ejection fraction; MACCE  major cerebrovascular and cardiac events; TIMI  Thrombolysis In MyocardialInfarction; other abbreviations as in Table 1.Table 3. Association Between Markers of Necrosis and Parameters Related to Myocardial Reperfusion
Pre-AMI Angina (n  18) No Pre-AMI Angina (n  12) p Value
Peak creatine kinase (U/l) 529 (252–1,446) 1,145 (379–2,554) 0.16
Number of segments DE 0.0 (0.0–3.3) 1.0 (0.0–5.5) 0.43
DE mass (g) 0.0 (0.0–14.5) 1.1 (0.0–28.7) 0.53
Percent LV (%) 0.0 (0.0–19.1) 3.0 (0.0–29.4) 0.63
TMPG 2–3 (n  22) TMPG 0–1 (n  8)
Peak creatine kinase (U/l) 613.0 (252.5–1,144.3) 1,796 (686–2,836) 0.009
Number of segments DE 0.0 (0.0–1.3) 5.0 (2.3–8.3) 0.001
DE mass (g) 0.0 (0.0–1.1) 20.4 (10.4–35.6) 0.001
Percent LV (%) 0.0 (0.0–5.9) 29.4 (13.3–48.5) 0.001
ST-Segment Resolution
>50% (n  23) <50% (n  7)
Peak creatine kinase (U/l) 614.0 (253.0–1,407.0) 1,025 (445.0–2,854.0) 0.12
Number of segments DE 0.0 (0.0–2.0) 4.0 (2.0–6.0) 0.01
DE mass (g) 0.0 (0.0–5.4) 18.1 (11.3–30.3) 0.01
Percent LV (%) 0.0 (0.0–5.9) 23.5 (11.8–35.3) 0.007
Acute Myocardial Infarction Location
Anterior (n  14) Inferior (n  16)
Peak creatine kinase (U/l) 1,085.5 (287.8–2,177.5) 528.5 (265.0–1,304.0) 0.16
Number of segments DE 3.5 (0.0–6.0) 0.0 (0.0–1.8) 0.02
DE mass (g) 5.9 (0.0–22.1) 0.0 (0.0–10.9) 0.11
Percent LV (%) 8.9 (0.0–35.3) 0.0 (0.0–10.3) 0.05
Values are n (interquartile range).
LV  left ventricle; TMPG  Thrombolysis In Myocardial Infarction myocardial perfusion grade; other abbreviations as in Table 1.
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(r  0.57, p  0.001).
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1078ndependent prognostic information after an AMI
4,7,8). However, the ejection fraction, a strong
redictor of death after MI (21), depends on the
Figure 2. Myocardial Delayed Enhancement in a Patient With Fa
Anterior wall ST-segment acute myocardial infarction in a 55-year-o
with stent implantation in the proximal left anterior descending art
Electrocardiographic ST-segment resolution was 50%, and peak cr
tomography performed 30 min after the last contrast injection (tota
ment myocardium in the anterior LV wall. The top panel shows the
from base to apex (A to D) are displayed below. Ao  aorta; LA 
right ventricle; other abbreviations as in Figure 1.
2 4 6 8 10 12 14
N Segments with Delayed Enhancement
=263.88x + 545.21
=0.57, p<0.001
Between Creatine Kinase Levels and the Extent of
t
orrelation (Spearman correlation coefﬁcient) between peak creat-
he number of segments with delayed enhancement is shownroad and might be normal in patients with akinetic
reas with hyperkinetic remote myocardium.
The use of DE-MDCT offers clinicians the unique
bility to identify the extent, localization, and morphol-
gy of irreversibly damaged myocardium immediately
fter primary PCI. More importantly, it can be achieved
n a few seconds, without further contrast administration,
nd by the use of a low radiation dose. The capability of
E-MDCT to provide an early discrimination between
iable (Fig. 4) and nonviable myocardium renders the
echnique a potential additional tool for risk stratification
f reperfused AMI patients. Detection of nonviable
yocardium may have an important influence on long-
erm ventricular geometry and function (22). Further-
ore, it might prevent risks related to eventual further
evascularization procedures when the potential benefit
o be obtained is uncertain.
A previous seminal report has explored the agree-
ent between DE-MDCT performed immediately
fter angiography in an AMI setting and low-dose
obutamine echocardiography (15). To our knowl-
dge, our study is the first study to explore the
Microvascular Reperfusion
an without pre-infarction angina who underwent primary PCI
A post-procedural TIMI ﬂow grade 3 was achieved with TMPG 0.
ne kinase was 4,432 U/l. Noncontrast multidetector computed
lume 250 ml) detected extensive transmural delayed-enhance-
tical long axis (left) and 3-chamber views, whereas the short axis
atrium; LV  left ventricle; RCA  right coronary artery; RV iled
ld m
ery.
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1079eperfusion and the presence of myocardial damage
easured by DE-MDCT without further iodine
njection immediately after primary PCI.
In line with previous reports demonstrating that
linical outcomes are not only associated with final
ngiographic flow in the epicardial artery but also
ith angiographic flow in the myocardium (2–5), in
he present study, all patients with impaired flow at
he microvascular level (TMPG 0 to 1) showed DE
n the infarct-related artery territory, whereas only
7% of patients with normal or near-normal micro-
ascular flow (TMPG 2 to 3) showed DE. In
arallel, 86% of patients with poor (50%) ECG
T-segment resolution showed DE areas, whereas
yperenhancement was seen in only 35% of patients
ith 50% ECG ST-segment resolution.
Patient demographics were not related to the pres-
nce of DE. However, hypercholesterolemia appeared
o act as a protective factor, although our data do not
upport a beneficial effect of statins. Pre-infarction
ngina, which has been recognized as a protective
actor against death and heart failure (23) attributed by
ifferent authors to a higher likelihood of presenting
ultiple vessel disease, preconditioning, and/or exten-
ive collateral development (24,25), was not associated
o the presence of DE.
Patients with inferior wall AMI were more likely
o have viable myocardium. Of note, 64% of pa-
Figure 4. Absence of Delayed-Enhancement in a Patient With S
Short-axis (A), horizontal long-view (4-chamber) (B), and vertical lon
farction angina and an inferior ST-segment acute myocardial infarct
after the last contrast injection (total volume 250 ml). The TIMI and
Table 4. Temporal Changes in LVEF According to the Presence
All (n  22)
LVEF baseline (%) 50.5 11.4
LVEF follow-up (%) 55.7 13.7
Absolute difference LVEF 6.4 (1.0 to 11.0)
Relative difference LVEF (%) 8.4 (2.9 to 20.0)
Values are reported as mean  SD or median (interquartile range), as indicate
Abbreviations as in Tables 1 and 2.enhancement was detected in the myocardium. Abbreviations as in Figients with anterior AMI showed DE myocardium,
hereas 69% of patients with inferior AMI had viable
yocardium. In addition, inferior wall AMIs showed
ignificantly smaller infarct extension. These findings
re in line with a seminal report that demonstrated
ignificantly lower peak enzyme levels and lower rates
f in-hospital mortality, congestive heart failure, and
onduction defects in patients with inferior wall AMI
ompared with anterior wall AMI (26).
Overall, our findings indicate that in the setting
f STEMI, patients with myocardium DE at non-
ontrast multidetector CT performed immediately
fter primary PCI are more likely to have failed
eperfusion at the microvascular level, whereas via-
le myocardium identified as the absence of DE
as associated to normal microvascular flow and
CG ST-segment resolution. Although 6-month
utcome was similar, patients with myocardium
E showed larger enzyme release, worse pre-
ischarge LVEF, and a greater rate of in-hospital
omplications compared with patients without DE.
tudy limitations. In our institution, the catheteriza-
ion laboratory is next to the CT room, which
llowed a median delay of 16 min between the last
ontrast injection and the CT scan. We acknowl-
dge that this time frame is unlikely to be achieved
n most hospitals; however, myocardium DE can be
ssful Reperfusion
ew (2-chamber) (C) in a 50- year-old female patient with pre-in-
(note stent in the mid RCA of B). Scan was performed 16 min
PG obtained after primary PCI were of grade 3. No delayed
bsence of Myocardial DE
DE (n  10) Non-DE (n  12) p Value
44.4 12.1 55.6 8.1 0.02
48.1 16.8 62.0 5.6 0.01
0 (4.6 to 13.9) 7.9 (4.1 to 10.8) 0.47
5 (15.1 to 32.7) 14.2 (3.0 to 19.8) 0.39ucce
g-vi
ion
TMor A
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d.ure 2.
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1080dentified as late as 40 min after contrast injection
12). The present study included a relatively small
opulation. Studies with larger populations and
ong-term follow-up might address the clinical
mpact of these findings and whether the early
dentification of myocardial viability by means of
E-MDCT has an additive prognostic value on
op of the established parameters of reperfusion.
It is worth mentioning that the radiation dose in
his study might be further reduced using lower kv at
he expense of increased image noise (15,27). Finally,
he lack of additional contrast administration might
ave influenced the accurate discrimination between1998;97:2302–6. Coll Cardiol 2005O N C L U S I O N S
n the setting of STEMI, the absence of myocar-
ium DE at noncontrast multidetector CT per-
ormed immediately after primary PCI was associ-
ted to normal microvascular flow and ECG ST-
egment resolution.
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